FDA Warning Letter — Lumis Global Pharmaceuticals Co. Ltd.
The FDA took a Warning Letter action against Lumis Global Pharmaceuticals Co. Ltd. on March 2, 2017 (Wuhan, China). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.
Action Details
- Facility
- Lumis Global Pharmaceuticals Co. Ltd.
- Date
- March 2, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Center
- CDER
- Location
- Wuhan (China)